Brain injury induces phenotypic changes in astrocytes, known as reactive astrogliosis, which may influence neuronal survival. Here we show that brain injury induces inositol 1,4,5-trisphosphate (IP 3 )-dependent Ca 2+ signaling in astrocytes, and that the Ca 2+ signaling is required for astrogliosis. We found that type 2 IP 3 receptor knockout (IP 3 R2KO) mice deficient in astrocytic Ca 2+ signaling have impaired reactive astrogliosis and increased injuryassociated neuronal death. We identified N-cadherin and pumilio 2 (Pum2) as downstream signaling molecules, and found that brain injury induces up-regulation of N-cadherin around the injured site. This effect is mediated by Ca
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calcium signal | reactive astrocyte | translational repressor | stab wound A strocytes, a major type of glial cell in the brain, play essential roles not only in physiological functions, such as synaptic plasticity and hemodynamic responses (1) , but also in pathophysiological conditions, such as trauma, infection, ischemia, epileptic seizures and stroke. In response to brain injury, astrocytes undergo characteristic phenotypic changes known as reactive astrogliosis, which can exert both beneficial and detrimental effects on surrounding neurons (2) (3) (4) . Despite the importance of this process, the molecular mechanisms governing astrogliosis and the role of reactive astrocytes require further clarification.
Injury to the brain mobilizes astrocyte-reactivating factors, including ATP, endothelin 1 (ET1), glutamate, and inflammatory cytokines, as well as mechanical stress. These factors have been shown to evoke astrocytic Ca 2+ signals not only in culture, but also in acute brain slice preparations and in the brains of live animals (5-7). These findings raise the possibility that injury to the brain evokes astrocytic Ca 2+ signals, which in turn regulate reactive astrogliosis. However, injury-induced Ca 2+ signaling in astrocytes heretofore had not been observed in vivo, and the role of Ca 2+ signaling in pathophysiological processes after brain injury was not established.
In 1A, Fig. S1A , and SI Materials and Methods) (8) . We also found that the injury-induced astrocytic Ca 2+ signals persisted for more than 3 h (Fig. S1B) . We then studied the source of injury-induced astrocytic Ca 2+ signaling. Type 2 inositol 1,4,5-trisphosphate (IP 3 ) receptor (IP 3 R2) is the dominant intracellular Ca 2+ release channel in astrocytes (9, 10) , and agonist-induced Ca 2+ signals were absent in IP 3 R2KO neocortical astrocytes in acute slice preparations (Fig. S1C) . Thus, we examined the injury-induced Ca 2+ signal in IP 3 R2KO mice (11) and found that it was abrogated ( Fig. 1A) , indicating that injury to the brain mobilizes Ca 2+ via IP 3 R2 in astrocytes.
We then analyzed the role of Ca 2+ signals in astrogliosis in the IP 3 R2KO mice after a neocortical stab wound injury (SWI), produced by a 0.8-to 1.3-mm-long and 0.5-to 0.8-mm-deep incision (12, 13) . SWI is expected to generate Ca 2+ signals in a larger population of astrocytes compared with a small laser ablation injury, making biochemical and histochemical analyses around the injury site more feasible. At 5 d after SWI, we tested for expression levels of glial fibrillary acidic protein (GFAP), an astrocytic marker that is up-regulated in reactive astrocytes, in astrocytes surrounding the injury site in control animals and in IP 3 R2KO mice. In the control animals, increased levels of GFAP expression were detected, often accompanied by polarized processes directed toward the injury site. In IP 3 R2KO mice, these changes associated with reactive astrogliosis were reduced (Fig. 1B  and Fig. S2 ). The attenuation of SWI-induced GFAP up-regulation in IP 3 R2KO mice continued over a 14-d period (Fig. 1C) (14, 15) . (See also Fig. S4C .) In neocortical astrocytes expressing 5ppase from an adenovirus vector, we found weak SWI-induced GFAP up-regulation, confirming our findings in the IP 3 R2KO mice (Fig. 1D) .
Reactive astrogliosis is thought to enhance neuroprotection and prevent inflammatory cell infiltration into the neural parenchyma after injury (3, 12) . To test whether injury-induced astrocytic Ca 2+ signals are important for these functions of reactive astrocytes, we measured the abundance of these cells in the SWI model. We found significantly more infiltrating leukocytes, observed as CD45 + round cells (12) , and fewer surviving neurons around the injury site in the IP 3 R2KO mice compared with control mice ( Fig. 1 E and F) . We confirmed that the IP 3 R2KO mice had no overt abnormalities in cortical histology, consistent with previous reports (10) . Before injury, GFAP immunoreactivity and the density of CD45 + leukocytes were comparable in the IP 3 R2KO and control littermate mice (Fig. S3) . Similarly, IP 3 R2 gene disruption caused no significant alteration in the immunoreactivity of ionized calcium-binding adapter molecule 1 (Iba1), a marker for microglia, which is implicated in reactive astrogliosis (16) (Fig. S3) . These results suggest the involvement of injury-induced astrocytic Ca 2+ signals in the cellular functions of reactive astrogliosis. We next explored the mechanisms of Ca 2+ -dependent reactive astrogliosis. We first compared gene expression profiles between Ca 2+ signal-silent and -active astrocytes in culture (SI Materials and Methods). Among highly down-regulated genes in Ca 2+ signal-active astrocytes (Table S1 ), Pum2 drew our immediate attention because of its capacity as a translational repressor (17, 18) . The decrease in Pum2 expression level in Ca 2+ signal-active astrocytes was confirmed by quantitative PCR analysis (29.8 ± 5.1% compared with control) and Western blot analysis (Fig. S4A ). Proteins whose translation is regulated by Pum2 are expected to be Ca 2+ -dependently up-regulated. We focused on N-cadherin as a potential target of Pum2 for several reasons. First, we previously found that N-cadherin is Ca 2+ -dependently up-regulated in astrocytes (14) . Second, there is an evolutionarily conserved potential Pum2-binding sequence (17) in the 3′ UTR of N-cadherin mRNA (Fig. S4B) . Third, N-cadherin is up-regulated in reactive astrocytes (19, 20) , although its role in reactive astrogliosis remains elusive. In line with this notion, we found that Ca 2+ -mobilizing agonists ATP and ET1 induced down-regulation of Pum2 and up-regulation of N-cadherin in cultured astrocytes (Fig. 2 A and B and Fig. S4 C and D) .
Because the 3′ UTR of N-cadherin mRNA harbors the potential Pum2-binding sequence, we examined the possibility that Pum2-dependent translational repression is involved in the regulation of N-cadherin expression in cultured astrocytes. Expression of red fluorescent protein (RFP)-tagged Pum2 (RFP-Pum2) reduced the basal expression level of N-cadherin, whereas Pum2 without its RNA-binding domain (RFP-Pum2Δ) had no effect (Fig. 2C) . Moreover, the expression of Pum2-activity reporter, consisting of a GFP coding sequence fused to the N-cadherin 3′ UTR sequence, was significantly reduced in astrocytes expressing RFP-Pum2 (Fig. 2D) . The suppressive effect of Pum2 was abrogated by removal of the Pum2-binding sequence from the reporter or by replacement of the 3′ UTR sequence with that of E-cadherin mRNA (Fig. 2D) . The expression of RFPPum2Δ had no effect on the expression level of all reporters. These results indicate that interaction between Pum2 and the Pum2-binding sequence in the 3′ UTR of N-cadherin mRNA mediates down-regulation of N-cadherin.
Injury-Induced Astrocytic Ca
2+ Signals Regulate Expression Levels of Pum2 and N-Cadherin. To study the role of Pum2 and N-cadherin in brain injury, we examined the expression levels of these molecules in vivo in the SWI model. Before injury, the adult neocortex expressed a significant amount of Pum2, whereas N-cadherin expression was barely detectable in both control and IP 3 R2KO mice (Fig. 3A) . After SWI, Pum2 expression was significantly reduced and N-cadherin expression was markedly increased around the injury site in control mice, whereas these changes were significantly attenuated in IP 3 R2KO mice ( Fig. 3 A and B) . These SWI-induced changes in Pum2 and N-cadherin expression were confirmed by Western blot analysis using tissue samples collected within 0.5-1.0 mm of the SWI site (Fig. 3C ). After SWI, Pum2 expression levels were 57 ± 9% of the contralateral expression level in control mice and 85 ± 8% of that in IP 3 R2KO mice, and respective N-cadherin expression levels were 289 ± 9% and 147 ± 13%.
To verify the responsibility of Pum2 for N-cadherin up-regulation in reactive astrocytes, we extrinsically expressed Pum2 in neocortical astrocytes using an adenoviral vector and then applied the SWI. Astrocytes overexpressing RFP-Pum2 showed significantly less N-cadherin up-regulation after SWI compared with control astrocytes transduced with a virus encoding RFP alone (Fig. 3D) . These findings suggest that Pum2 keeps N-cadherin expression at a low level in quiescent astrocytes, and that after SWI, astrocytic Ca 2+ signals down-regulate Pum2, which in turn leads to the upregulation of N-cadherin through attenuation of Pum2-mediated translational repression.
Up-Regulation of Astrocytic N-Cadherin Is Indispensable for Neuroprotection. We next examined the possibility that Ca 2+ -dependent N-cadherin up-regulation has a role in astrogliosis and neuroprotection. To study this possibility, we generated astrocytespecific N-cadherin knockout (aNcadKO) mice, crossing N-cadherin floxed mice (21) and tamoxifen (Tx)-inducible Cre recombinaseexpressing mice that is driven by the astrocyte specific L-glutamate/ L-aspartate transporter promoter (GLAST-CreERT2) (22) , and activated Cre recombinase by administration of Tx to adult mice. After SWI, GFAP immunoreactivity and the extent of morphological changes were significantly reduced in aNcadKO mice compared with control mice (Tx-administrated N-cadherin floxed mice without the GLAST-CreERT2 gene) ( Fig. 4A and Fig. S5 ). We observed no significant effect of Tx administration on GFAP immunoreactivity or neuronal density before SWI (Fig. S6A ). In addition, N-cadherin expression level before SWI was not significantly different in control and aNcadKO mice (Fig. S6B) , suggesting that neuronal N-cadherin expression in aNcadKO mice is not down-regulated. However, on injury, N-cadherin upregulation was markedly inhibited in aNcadKO mice (Fig. S6B) . The slight up-regulation of N-cadherin in aNcadKO mice after SWI is likely produced by the population of astrocytes that escaped Cre-dependent recombination; recombination efficiency in these mice is ∼60% (22) . Taken together, these results indicate that N-cadherin up-regulation is required for reactive astrogliosis after SWI. In support of this notion, we found that SWI-induced down-regulation of Pum2 in aNcadKO mice was comparable to that in control littermate mice (Fig. S6B) .
We next performed an in vitro scratch wound assay (23, 24) to study the role of N-cadherin in reactive astrogliosis. Scratch wound-induced migration of astrocytes is considered an important in vitro model of reactive astrogliosis, because astrocytic migration toward the injury core site is an essential process during reactive astrogliosis (25) . We found a more significant reduction in the distance of migration in N-cadherin-deficient astrocytes compared with control astrocytes (Fig. S7) .
Finally, we studied the effect of astrocyte-specific N-cadherin deficiency on leukocyte infiltration and neuroprotection. In aNcadKO mice, the number of CD45 + cells around the injury site was significantly increased, whereas the density of surviving neurons was significantly decreased (Fig. 4 B and C) . These phenotypes observed in aNcadKO mice are similar to those observed in IP 3 R2KO mice (compare Figs. 1 B, E, and F with Fig. 4) . Astrocyte-specific N-cadherin deficiency had no effect on the resting activity and SWI-induced activation of microglia (Fig. S8) .
Thus, we conclude that Ca 2+ signal-dependent up-regulation of N-cadherin in astrocytes regulates reactive astrogliosis and neuroprotection following brain injury.
Discussion
In this study, we have shown that injury-induced astrocytic Ca 2+ signals, acting with downstream Pum2 and N-cadherin, regulate reactive astrogliosis and neuroprotection after brain injury (Fig. 5) , thereby highlighting the importance of intracellular Ca 2+ signaling in the pathophysiological function of astrocytes. The requirement of IP 3 R2 in this Ca 2+ -dependent mechanism suggests that IP 3 -generating agonists such as ATP, ET1, and glutamate, which are released from the injured tissue, are likely to be the initiation signal. We also found that Pum2 mediates the Ca -dependent transcriptional factor or miRNA regulation. The precise nature of this regulation remains to be elucidated. Our data are consistent with a recent study showing that Ca 2+ influx across the plasma membrane regulates Pum2 expression level in neurons (29) . Thus, Ca 2+ dependent regulation of Pum2 appears to be common to both neurons and glia.
The putative Pum2-binding sequence is present in an array of mRNAs, suggesting that Ca 2+ -dependent Pum2 signaling regulates multiple potential targets. However, our data suggest that the dominant target of Ca 2+ -Pum2 signaling is likely N-cadherin. Specifically, whereas the effect of Ca 2+ signal disruption on both astrogliosis and neuroprotection in IP 3 R2KO mice was recapitulated in aNcadKO mice, the extent of injury-induced Pum2 down-regulation in aNcadKO mice was similar to that seen in control mice, suggesting that N-cadherin is the dominant target of Ca 2+ -Pum2 signaling in the experimental system presented here. Nonetheless, it will be important to explore other targets of Pum2 in various cellular functions. In addition to the Ca 2+ -dependent mechanism described in this study, other signaling cascades have been identified as mediators of reactive astrogliosis (3, 4, 30) . How these pathways collaborate to regulate the complex and multistep cellular processes in reactive astrogliosis remains to be studied.
N-Cadherin Regulates Reactive Astrogliosis and Neuroprotection.
Although the function of N-cadherin in neurons has been studied extensively, its function in glial cells has remained elusive. We found that N-cadherin up-regulation in astrocytes is essential for reactive astrogliosis and neuroprotection after brain injury. In previous studies, N-cadherin and its family proteins were initially characterized by their function in cell-cell adhesion, but were subsequently found to regulate other cellular functions as well, including differentiation, proliferation, cell polarization, migration, and gene expression (26) (27) (28) . These multiple functions of cadherin family proteins may underlie reactive astrogliosis.
N-cadherin in cultured astrocytes is known to regulate cell polarity, the essential determinant of the cell morphology and direction of migration (23, 31) . In line with this notion, aNcadKO astrocytes demonstrated defects in cell migration and morphological change after injury (Fig. 4A and Figs. S5 and S7) . N-cadherin binds the fibroblast growth factor receptor (FGFR) and activates the FGFR-dependent signaling cascade, which can enhance GFAP expression in cultured astrocytes (4, 26, 32) . This regulatory mechanism may underlie the defect of GFAP up-regulation in IP 3 R2KO, 5ppase-expressing, and aNcadKO astrocytes (Figs. 1B and D and 4A). Further work is needed to clarify the molecular mechanism of N-cadherin in reactive astrogliosis. (1) . In the present study, we focused on pathophysiological functions of astrocytes and found a significant phenotype of IP 3 R2KO mice regarding astrogliosis. Pathophysiological Ca 2+ signaling in neurons often has a deleterious effect on neurons and results in neuronal cell death (33, 34) . On the other hand, our present findings indicate that brain injury-induced Ca 2+ signaling in astrocytes drives astrocytic reactivation, which has beneficial effects on neurons around the injury site. In addition, microglial Ca 2+ signaling after brain injury mediates the clearance of dying cells (35) . Thus, in glial cells in the adult central nervous system, Ca 2+ signaling may have a tissue-protective role after brain injury.
In conclusion, the signaling pathway identified in this study highlights the importance of astrocytic intracellular Ca 2+ signaling in the beneficial effect of reactive astrocytes under pathophysiological conditions, and provides a platform to further characterize the cellular and molecular basis of reactive astrogliosis. (1, 2) , which lead to down-regulation of Pum2 (3). This in turn induces N-cadherin up-regulation (4) by relieving Pum2-mediated repression of N-cadherin translation. Up-regulated N-cadherin plays an essential role in reactive astrogliosis and neuroprotection (5) .
